戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 galovirus, EBV, adenovirus, BK virus, and/or human herpesvirus 6.
2 sivity factors of herpes simplex virus 1 and human herpesvirus 6.
3 reported types of clinical disease caused by human herpesvirus-6.
4  infection with both human herpesvirus-7 and human herpesvirus-6.
5  virus; cytomegalovirus; Epstein-Barr virus; human herpesviruses 6, 7, and 8; or adeno-associated vir
6                                              Human herpesvirus 6 activity (HHV-6) was studied in 15 a
7                       Coreactivation of both human herpesvirus 6 and cytomegalovirus in ICU patients
8                           The association of human herpesvirus 6 and cytomegalovirus reactivation wit
9 ilation and ICU type, only coreactivation of human herpesvirus 6 and cytomegalovirus was significantl
10 with the detection of cytomegalovirus (CMV), human herpesvirus 6 and human herpesvirus 7 and BK virus
11 -N also inhibited fusion and/or infection by human herpesvirus 6 and measles virus but not by vaccini
12                                              Human herpesvirus-6 and respiratory syncytial virus are
13                                              Human herpesviruses 6 and 7 (HHV-6 and HHV-7) are preval
14 s of the epidemiology and natural history of human herpesviruses 6 and 7 in infants, a practical meth
15 ing Epstein-Barr virus, cytomegalovirus, and human herpesviruses 6 and 7.
16  virus, cytomegalovirus, Epstein-Barr virus, human herpesviruses 6 and 8, gonorrhea, or chlamydia.
17 infections, such as measles, parvovirus B19, human herpesvirus 6, and enteroviruses in developed coun
18 uding BK virus, cytomegalovirus, adenovirus, human herpesvirus 6, and Epstein-Barr virus.
19  and 2, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, and varicella-zoster virus.
20 hain reaction to detect human herpesvirus-7, human herpesvirus-6, and cytomegalovirus DNA in lesional
21                                              Human herpesvirus-6 can be a pathogen in transplant reci
22                                              Human herpesvirus-6 can be an opportunistic pathogen in
23  inherits a chromosomally integrated copy of human herpesvirus 6 (CI-HHV-6), but the consequences of
24 esence of inherited chromosomally integrated human herpesvirus 6 (ciHHV-6) in hematopoietic cell tran
25 inical relevance of chromosomally integrated human herpesvirus-6 (CIHHV-6) after transplantation is n
26            Both CMV disease and detection of human herpesvirus 6 DNA were associated with chronic all
27 positivity for either human herpesvirus-7 or human herpesvirus-6 DNA in skin or serum.
28 lls (83%), and serum (100%) samples, whereas human herpesvirus-6 DNA was detected in lesional skin (8
29                                     Viruses (human herpesvirus 6, Epstein-Barr virus, and cytomegalov
30                                              Human herpesvirus-6 has two variants, designated variant
31 ding measles virus, Neisseria gonorrhea, and human herpesvirus 6, have been described, the region of
32              A potential association between human herpesvirus 6 (HHV-6) and cytomegalovirus (CMV) fo
33                                              Human herpesvirus 6 (HHV-6) and HHV-7 are closely relate
34 ral reports have suggested an association of human herpesvirus 6 (HHV-6) and multiple sclerosis (MS)
35                                              Human herpesvirus 6 (HHV-6) and oncogenic Marek's diseas
36 test was developed and used with an existing human herpesvirus 6 (HHV-6) antibody avidity test to det
37            Six immunocompetent patients with human herpesvirus 6 (HHV-6) chromosomal integration had
38                              The majority of human herpesvirus 6 (HHV-6) congenital infections (86%)
39          The prevalence and concentration of human herpesvirus 6 (HHV-6) DNA in the cerebrospinal flu
40                                              Human herpesvirus 6 (HHV-6) DNA levels in peripheral blo
41                             The frequency of human herpesvirus 6 (HHV-6) DNA was assessed in autopsy
42                                              Human herpesvirus 6 (HHV-6) employs the complement regul
43        This review evaluates publications on human herpesvirus 6 (HHV-6) encephalitis recognizing fir
44                 Following primary infection, human herpesvirus 6 (HHV-6) establishes a persistent inf
45 esignated DR7, within the SalI-L fragment of human herpesvirus 6 (HHV-6) exhibited transactivation of
46                                              Human herpesvirus 6 (HHV-6) has been implicated as a cof
47                    Several gene fragments of human herpesvirus 6 (HHV-6) have been shown to activate
48 mory subsets of CD4(+) and CD8(+) T cells to human herpesvirus 6 (HHV-6) have not been previously inv
49                                  The role of human herpesvirus 6 (HHV-6) in disease beyond primary in
50                          HHV-7 is related to human herpesvirus 6 (HHV-6) in terms of both biological
51                          Higher incidence of human herpesvirus 6 (HHV-6) infection has been documente
52                                              Human herpesvirus 6 (HHV-6) infection is common after tr
53                                   Congenital human herpesvirus 6 (HHV-6) infection results from germl
54 bella, 309 cases of dengue, and 260 cases of human herpesvirus 6 (HHV-6) infection.
55              Serologic studies indicate that human herpesvirus 6 (HHV-6) infects 90 percent of childr
56                                              Human herpesvirus 6 (HHV-6) is a lymphotropic betaherpes
57                                              Human herpesvirus 6 (HHV-6) is a lymphotropic herpesviru
58                                              Human herpesvirus 6 (HHV-6) is a potentially immunosuppr
59                                              Human herpesvirus 6 (HHV-6) is a ubiquitous T-lymphotrop
60                                              Human herpesvirus 6 (HHV-6) is detected in the plasma of
61 ugh first described as a lymphotropic virus, human herpesvirus 6 (HHV-6) is highly neuropathogenic.
62                                              Human herpesvirus 6 (HHV-6) is susceptible to latency an
63                                              Human herpesvirus 6 (HHV-6) species have a unique abilit
64                                              Human herpesvirus 6 (HHV-6) variant B is frequently iden
65                                              Human herpesvirus 6 (HHV-6) was detected in specimens fr
66                                              Human herpesvirus 6 (HHV-6), a common resident virus of
67                                              Human herpesvirus 6 (HHV-6), a latent lymphotropic and n
68                                    Recently, human herpesvirus 6 (HHV-6), a newly described beta-herp
69  the presence of herpes simplex virus (HSV), human herpesvirus 6 (HHV-6), Epstein-Barr virus (EBV), c
70 megalovirus (CMV), Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), herpes simplex virus types
71 er herpesviruses, including cytomegalovirus, human herpesvirus 6 (HHV-6), HHV-7, HHV-8, and Epstein-B
72 uses such as Marek's disease virus (MDV) and human herpesvirus 6 (HHV-6), integrate their DNA into ho
73 ted at the left and right genomic termini of human herpesvirus 6 (HHV-6), respectively.
74 r a candidate multiple sclerosis (MS) virus, human herpesvirus 6 (HHV-6), was sought in biopsy specim
75 ntly reactivated in HIV-infected patients is human herpesvirus 6 (HHV-6), which has been proposed as
76 have performed a screen aimed at identifying human herpesvirus 6 (HHV-6)-encoded proteins that modula
77 , cytomegalovirus (CMV), BK virus (BKV), and human herpesvirus 6 (HHV-6).
78 onent of multiple sclerosis, the neurotropic human herpesvirus 6 (HHV-6).
79        Human CD46 is a cellular receptor for human herpesvirus 6 (HHV-6).
80  required for its function as a receptor for human herpesvirus 6 (HHV-6).
81                          Here, we describe a human herpesvirus 6 (HHV-6A) chemokine, U83A, which bind
82 96-102), a candidate autoantigen for MS, and human herpesvirus-6 (HHV-6 U24, residues 4-10) that is a
83                                              Human herpesvirus-6 (HHV-6) and -7 (HHV-7) infections ty
84            In addition, viral copy number of human herpesvirus-6 (HHV-6) and human herpesvirus-7 (HHV
85         The clinical impact and relevance of human herpesvirus-6 (HHV-6) infection in liver transplan
86                       To investigate whether human herpesvirus-6 (HHV-6) is a causative agent of ence
87                                              Human herpesvirus-6 (HHV-6) is a neurotropic virus that
88                                              Human herpesvirus-6 (HHV-6) is a neurotropic virus.
89                                              Human herpesvirus-6 (HHV-6) is known to reactivate after
90         Previous research has suggested that human herpesvirus-6 (HHV-6) may integrate into host cell
91                     A real-time quantitative human herpesvirus-6 (HHV-6) polymerase chain reaction as
92                         The new herpesvirus, human herpesvirus-6 (HHV-6), is able to cause clinical i
93 ZV); beta includes cytomegalovirus (CMV) and human herpesvirus-6 (HHV-6); and gamma includes Epstein-
94                   Recent studies have linked human herpesviruses 6 (HHV-6) and 7 (HHV-7) with posttra
95 (EBV), BK virus (BKV), adenovirus (ADV), and human herpesvirus 6 (HHV6) were evaluated to determine o
96 omes of interest were VR of adenovirus, EBV, human herpesvirus 6 (HHV6), cytomegalovirus (CMV), and B
97 , enterovirus, herpes simplex virus 1 and 2, human herpesvirus 6, human parechovirus, varicella-zoste
98           Inherited chromosomally integrated human herpesvirus-6 (iciHHV-6) results in the germ-line
99 ations in ATRX and CTNNB1 and integration of human herpesvirus-6 in chromosome 11p.
100 enabled detection of human herpesvirus-7 and human herpesvirus-6 in skin and other tissues isolated f
101        CMV, herpes simplex virus type 1, and human herpesvirus 6 infection were independently associa
102  and efficacy of prophylactic strategies for human herpesvirus-6 infection in transplant recipients.
103                               Prophylaxis of human herpesvirus-6 infection is feasible in transplant
104 miology, clinical features, and treatment of human herpesvirus-6 infection were manually abstracted f
105                                              Human herpesvirus 6 is associated with a variety of comp
106                                              Human herpesvirus 6 is the causative agent of roseola in
107 rompt recognition of disease associated with human herpesvirus-6 is important because this virus is s
108 ncluding adenovirus, bocavirus, coronavirus, human herpesvirus-6, lymphocytic choriomeningitis virus,
109 cause it can depress cell-mediated immunity, human herpesvirus-6 may facilitate superinfection by oth
110 ear cells expressing human herpesvirus-7 and human herpesvirus-6 mRNA were identified in perivascular
111 9; p = 0.005) compared to patients with only human herpesvirus 6, only cytomegalovirus, or no viral r
112 30 febrile children positive for adenovirus, human herpesvirus 6, or enterovirus infection or with ac
113 ohistochemical staining for the P41 and P101 human herpesvirus 6 protein antigens showed numerous imm
114             The marrow-suppressive effect of human herpesvirus-6 ranged from transient or self-limite
115                           Most patients with human herpesvirus 6 reactivation also reactivated cytome
116 ical ventilation, burn ICU, major infection, human herpesvirus 6 reactivation, and cytomegalovirus re
117 y and comprehensively assessed the impact of human herpesvirus 6 reactivation, and its interaction wi
118                                              Human herpesvirus-6 resembles cytomegalovirus in its ant
119 pinal fluid studies revealed the presence of human herpesvirus 6, variant B, DNA in all of 3 patients
120                                        As do human herpesvirus 6 variants A and B (HHV-6A and -6B), H
121                                              Human herpesvirus 6 variants A and B (HHV-6A and HHV-6B)
122                                              Human herpesvirus 6 viremia occurred in 23% of patients
123 ied through a MEDLINE search from 1986 (when human herpesvirus-6 was discovered) to the present, bibl
124 stein-Barr virus (EBV), cytomegalovirus, and human herpesvirus 6 were assessed by semiquantitative po

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top